InsidersTradesSigma
Follow the SAGIMET BIOSCIENCES INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €576.8m. The latest transaction was disclosed on 14 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: GEORGE KEMBLE. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
SAGIMET BIOSCIENCES INC is a biotechnology company focused on developing treatments for metabolic and liver diseases. It emphasizes innovation in the healthcare sector.